Zeo ScientifiX Files S-1 for Public Offering

Ticker: ZEOX · Form: S-1 · Filed: Mar 26, 2025 · CIK: 1557376

Sentiment: neutral

Topics: ipo, registration, biotech

TL;DR

Zeo ScientifiX (fka Organicell) just filed an S-1, signaling a potential IPO or secondary offering.

AI Summary

Zeo ScientifiX, Inc. filed an S-1 form on March 26, 2025, to register its securities. The company, formerly known as Organicell Regenerative Medicine, Inc., is in the biological products sector and is incorporated in Nevada. Its business address is in Davie, Florida.

Why It Matters

This S-1 filing indicates Zeo ScientifiX is preparing to offer its securities to the public, which could lead to significant capital infusion and increased trading activity.

Risk Assessment

Risk Level: medium — As an S-1 filing, it represents a company seeking to go public, which inherently carries risks associated with market volatility and early-stage company performance.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Zeo ScientifiX, Inc.?

Zeo ScientifiX, Inc. operates in the BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) sector, with SIC code 2836.

When did Zeo ScientifiX, Inc. change its name from Organicell Regenerative Medicine, Inc.?

The company changed its name on June 25, 2018 (20180625).

What is the state of incorporation for Zeo ScientifiX, Inc.?

Zeo ScientifiX, Inc. is incorporated in Nevada (NV).

What is the fiscal year end for Zeo ScientifiX, Inc.?

The company's fiscal year ends on October 31 (1031).

What is the business address of Zeo ScientifiX, Inc.?

The business address is 3321 COLLEGE AVENUE, SUITE 246, DAVIE, FL 33314.

Filing Details

This Form S-1 (Form S-1) was filed with the SEC on March 26, 2025 regarding Zeo ScientifiX, Inc. (ZEOX).

View full filing on EDGAR

View Full Filing

View this S-1 filing on SEC EDGAR

View on Read The Filing